Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II, IVA and VI-Reference-Cited by-同舟云学术

Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II, IVA and VI

Published:2016-04 Issue:4 Volume:117 Page:431-437
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

Lin Hsiang-Yu,Chuang Chih-Kuang,Chen Ming-Ren,Lin Shan-Miao,Hung Chung-Lieh,Chang Chia-Ying,Chiu Pao Chin,Tsai Wen-Hui,Niu Dau-Ming,Tsai Fuu-Jen,Lin Shio Jean,Hwu Wuh-Liang,Lin Ju-Li,Lin Shuan-Pei

Funder

National Science Council, Taiwan

Mackay Memorial Hospital

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference40 articles.

1. Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management;Braunlin;J. Inherit. Metab. Dis.,2011

2. Mucopolysaccharidosis: cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI;Brands;J. Inherit. Metab. Dis.,2013

3. The mucoplysaccharidoses;Neufeld,2001

4. Neurochemical changes and therapeutical approaches in mucopolysaccharidoses;Chuang,2007

5. Incidence of the mucopolysaccharidoses in Taiwan, 1984–2004;Lin;Am. J. Med. Genet. A.,2009

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic cell transplantation for Mucopolysaccharidosis I in the presence of decreased cardiac function;Molecular Genetics and Metabolism;2023-11

2. Natural history of cardiac findings in mucopolysaccharidosis type I: report from an international registry;Cardiology in the Young;2023-10-18

3. Evaluation of cardiac findings in mucopolysaccharidosis;The International Journal of Cardiovascular Imaging;2023-10-17

4. Metabolic Cardiomyopathies and Cardiac Defects in Inherited Disorders of Carbohydrate Metabolism: A Systematic Review;International Journal of Molecular Sciences;2023-05-11

5. Preclinical Enzyme Replacement Therapy with a Recombinant β-Galactosidase-Lectin Fusion for CNS Delivery and Treatment of GM1-Gangliosidosis;Cells;2022-08-19